Danazol: molecular, endocrine, and clinical pharmacology.
article
OA: closed
CC0
⤵ 12 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper explores the molecular, endocrine, and clinical pharmacology of danazol, a synthetic steroid used to treat conditions like endometriosis and fibrocystic breast disease.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (12)
- Androgen Signaling in Uterine Diseases: New Insights and New Targets 2022
- Adenomyosis: a systematic review of medical treatment 2016
- History of Endometriosis: A 20th‐Century Disease 2011
- Diagnosis and treatment of endometriosis 2003
- A Benefit-Risk Assessment of Medical Treatment for Uterine Leiomyomas 2002
- Endometriosis: novel etiopathogenetic concepts and clinical perspectives 2002
- Medical management of endometriosis and infertility 2000
- Danazol relieves refractory pruritus associated with myeloproliferative disorders and other diseases 1996
- [<sup>3</sup>H]Dexamethasone Binding Activity in Liver Microsomes is Modulated Differently by 17 α‐Alkylated Androgens and Testosterone<i>in vivo</i> 1995
- Danazol in the Treatment of Menorrhagia: The Effect of a 1 Month Induction Dose (200 mg) and 2 Month's Maintenance Therapy (200 mg, 100 mg, 50 mg or placebo) 1992
- Danazol for urinary incontinence in tropical spastic paraparesis 1992
- Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis 1992
Source provenance
- europepmc
- last seen: 2026-10-04T09:26:46.659050+00:00
- openalex
- last seen: 2026-05-10T10:20:29.515715+00:00
- pubmed
- last seen: 2026-05-13T22:12:15.619952+00:00
License: CC0
· commercial use OK